We are thrilled to share the news of Equalizer Exchange’s migration to the Sonic network. This move marks a significant milestone for our DeFi application, aligning with our commitment to continuous growth and innovation. To ensure a smooth transition and uphold the integrity of our community, the migration will occur on a 1:1 basis. Our native token on the Sonic network will retain its existing ticker, $EQUAL, reflecting the strong support it has received from our community.

What to Expect During the Migration

1:1 Token Swap
EQUAL and veEQUAL tokens on the Fantom network can be exchanged on a 1:1 basis for EQUAL tokens on the Sonic network. This straightforward swap maintains value parity and offers a seamless experience for all token holders. Both veEQUAL and EQUAL tokens will migrate at this ratio, ensuring everyone’s holdings are preserved.

Emission Adjustments Based on Migration Participation

The emissions of EQUAL tokens will be adjusted based on the proportion of tokens migrated to the Sonic network. For instance, if 90% of veEQUAL tokens are transferred, the emissions will be set to 90% of the current Epoch total, aligning with our existing decay model. After the migration, EQUAL positions will be claimable after deployment, allowing users to direct emissions accordingly.

For Holders Choosing to Stay on Opera

We understand that some of our community members may choose to remain on the Fantom network (Opera). For those who decide not to migrate, the emissions will be adjusted to reflect the remaining percentage of veEQUAL positions on Opera. You will continue to have 100% governance rights over the Opera instance of Equalizer and we will maintain dApp support on the chain. Future development and token listings on Opera will depend on its performance following the Sonic migration.

Migration Timeline

You will have the opportunity to allocate your tokens to the migration contract up until the Sonic network launches (Current target is December 2024). The migration contract will be available as soon as it is ready, but note that it is a one-time deposit. Therefore, make sure to choose the optimal moment for you. Many might prefer to allocate their positions closer to the launch date of Sonic to remain active on Opera for as long as possible.

The current Equalizer ecosystem will essentially be split into two independent ecosystems, with the current holders being given a choice to either stay or migrate.

The net total supply of EQUAL combined across both opera and sonic versions will stay constant / no extra tokens will be minted.

Technical and Logistical Details

For technical reasons and to manage gas costs, you will receive one max locked veEQUAL position on Sonic per wallet address. If you prefer to keep your veEQUAL assets as separate NFTs, we suggest creating unique addresses for each NFT submission. This approach might require some advance preparation but will ensure your assets on Equalizer Sonic align with your preferred wallet structure.

A migration dApp will be provided to the community, displaying veEQUAL and EQUAL tokens currently seeded for migration. This tool is designed to maintain transparency and assist you in making informed decisions regarding your migration strategy.

Why should you be excited about Equalizer on Sonic

The launch on Sonic brings an expansive gateway with the potential to connect Equalizer to other networks and untapped liquidity sources. With the introduction of Sonic’s gateway, Equalizer will seamlessly expand the reach and impact of our liquidity offerings. The newly established connections will open the door for larger volumes and higher liquidity efficiency, positioning Equalizer as a pivotal player in the new Sonic environment.

Our migration to Sonic coincides with a major incentive program: the launch of $S rewards. With incentives slated to reach hundreds of millions of dollars, this program is designed to attract new participants, showcase Sonic’s speed and technical prowess, and fuel the rapid growth of a thriving ecosystem. Equalizer will capitalize on this momentum, evolving its role from being the proven liquidity layer on the Fantom Opera network to becoming the Sonic’s key liquidity infrastructure component.

As we enter this new chapter, Equalizer will continue to prioritize the values that have made it successful: robust liquidity management, transparent governance, and a commitment to supporting the community. Our mission remains focused on delivering innovative, sustainable solutions that adapt to the ever-changing landscape of DeFi.

This migration is an exciting step forward for Equalizer allowing us to unlock the endless new capabilities of Sonic. A strategic step towards expanding Equalizer Exchange’s capabilities within the Sonic ecosystem. We are confident that this transition will unlock new opportunities for growth and innovation, benefiting all participants in our community. We look forward to embarking on this new journey together and thank you for your continued support.

Link

Though Tesla’s (NASDAQ: TSLA) history with Bitcoin (BTC) mostly ended in July 2022, when the electric vehicle (EV) maker sold about 75% of its cryptocurrency, it experienced an unexpected revival on October 15 and 16, 2024.

Specifically, Tesla started moving vast quantities of BTC to previously unknown addresses on the afternoon of October 15 and had, across a total of 26 transactions, transferred some $760 million worth of the coin, per the data retrieved from Arkham Intelligence.

The transfers – which involve virtually all of Tesla’s remaining 11,510 Bitcoins – quickly drew the crypto community’s attention and sparked speculation on the EV maker’s intentions.

Is Tesla planning to remove its Bitcoin exposure?

Perhaps the most obvious explanation – though not necessarily true – is that Tesla is preparing to sell its remaining Bitcoin. 

Indeed, the EV maker’s wallet remained dormant during much of the ‘crypto winter’ – when BTC was mostly trading below $20,000 – and came to life in ‘Uptober’ of 2024 after the cryptocurrency had experienced a protracted period of strong performance.

So far, Bitcoin is up 58.89% in 2024 and had risen to $67,708 by press time on October 16. Simultaneously, the most recent trading saw BTC break its summertime downtrend and again appear poised to try and hit a new all-time high.

Such a setup would make selling the cryptocurrency lucrative for Tesla, and as its current situation and historical actions demonstrate, it has an incentive to make a quick buck in the cryptocurrency markets.

How Tesla came to own Bitcoin

Though intentional ill-doing was never confirmed, Tesla’s original brush with Bitcoin remains somewhat controversial. In January 2021, the EV maker invested approximately $1.5 billion in BTC, and in March of the same year, the firm revealed it would accept the cryptocurrency as payment.

Thanks to Musk’s popularity and reputation and Tesla’s overall importance, the revelations helped Bitcoin experience a substantial rally from its January 2, 2021, price of approximately $31,000 to about $58,000 on March 20 of the same year.

While the community initially welcomed the moves, they quickly drew criticism as, in April 2021, Tesla sold a part of its BTC, making more than $100 million in profits and, just weeks later, in May, Musk said his firm would no longer accept the cryptocurrency due to environmental concerns.

Is Tesla using Bitcoin to improve quarterly financials?

Not only did the sequence of events raise some allegations of market manipulation, but it also – together with environmental tax credits – had a meaningful impact on Tesla’s quarterly results.

In October 2024, Tesla is again likely to face a week-long quarterly report due to the pressure from the prevailing ‘EV winter’ and the immediate lack of success for the recent ‘We, Robot’ event.

Still, while selling the $770 million worth of Bitcoin would positively impact Tesla’s financials, these would be reflected only in the report covering the final trimester of 2024. 

Furthermore, no market manipulation or other unsavory activity was proven in 2021 – even though crypto traders faced a 12% BTC downturn within a day after Tesla stopped accepting the cryptocurrency.

Additionally, though some of the events indicate Musk partially influencing and partially just taking advantage of BTC’s movements, it is worth pointing out that the 2022 sale of the majority of the EV maker’s cryptocurrency was executed at a loss.

Ultimately, though there is plenty of room – and some backing – for theories centered on Tesla planning to sell its BTC, perhaps even to bolster its future reports with a major realized crypto market gain, it is equally possible the move is either a simple reshuffling of assets or an innocent attempt to make back some of the original investment.

Still, cryptocurrency traders should be wary of Tesla’s possible selling as the sudden inflows of such a quantity of BTC into the market could cause significant downward pressure.

Link

Pharmaceutical companies are exploiting populations year-after-year, fine tuning the name of illnesses annually and marketing new cures that only make people sicker. Beginning this fall, Japan will introduce a self-amplifying mRNA COVID-19 vaccine as part of its vaccination program for the 2024-2025 fall and winter seasons. The vaccine, Kostaive (ARCT-154), will be available for 7,000 yen ($47) to individuals aged 65 and older, as well as those aged 60 to 64 with severe underlying health conditions. It is part of a two-dose series.

In clinical trials, a near 90 percent adverse event rate was recorded after the first dose. These adverse events were disregarded, however, as Japan approved the jab. The United States is also looking to approve these jabs in the coming years.

World’s first self-amplifying mRNA vaccine will be released in Japan

ARCT-154 became the world’s first self-amplifying mRNA COVID-19 vaccine after receiving approval from Japan’s Ministry of Health, Labour, and Welfare in November 2023. It was developed by biotechnology firm CSL in collaboration with Arcturus Therapeutics.

Unlike mRNA vaccines — which only produce the spike protein necessary for immune response as long as the mRNA persists — saRNA vaccines are engineered to create copies of themselves and the proteins they encode. This "biological printing press" could theoretically amplify the vaccine’s presence and multiply its effects within the body indefinitely.

According to CSL, the vaccine demonstrated higher immunogenicity and a favorable safety profile compared to original mRNA vaccines during clinical trials. However, independent vaccine researchers are voicing serious concerns regarding the safety and efficacy of this untested technology.

Dr. Nicolas Hulscher stated, “These products are completely new. There is absolutely no long-term safety data on them.” In trials for ARCT-154, he noted a near 90 percent adverse event rate after the first dose, with clinicians observing significant systemic reactions in participants. Serious and medically-attended adverse events were only recorded from Day 1 to Day 92.

Karina Acevedo Whitehouse, a microbiology professor, emphasized the lack of comprehensive studies on the long-term effects of self-amplifying mRNA technology. She pointed out that there are no assessments of potential cellular transformations, including the risks of cancerous mutations or inflammatory responses. “We simply do not know what the consequences could be,” she warned.

“There have also been no studies conducted on trans-generational effects — for instance, teratogenicity [birth defects] — of self-amplifying mRNA injections,” she said. “We simply do not know what the consequences could be.”

Further raising concerns, a Cambridge University study revealed that original mRNA vaccines could trigger unintended immune responses in a third of recipients, leading to possible autoimmune reactions. Whitehouse linked the increase in certain cancers observed since 2021 to the effects of mRNA technology on cellular pathways.

Self-amplifying mRNA vaccines, which include an enzyme that allows for the replication of the injected mRNA, may pose even greater risks than the original mRNA vaccines. Experts suggest that the sustained antigen production could lead to heightened risks, making these new vaccines akin to “conventional mRNA injections on steroids,” as Hulscher described.

U.S. considers using self-amplifying mRNA vaccines, which are really runaway bioweapons

The United States is planning to use these new vaccines. The Biden regime has already partnered with several companies to develop self-amplifying mRNA vaccines for future plandemics. In other words, companies are conspiring to create a line of self-amplifying vaccines so they can profit from future virus constructs and subsequent pandemic messaging and vaccine marketing campaigns. CastleVax, Codagenix and Gritstone Bio have already received contracts from the Department of Health and Human Services under the federal government’s Project NextGen.

Project NextGen claims to accelerate and streamline the rapid development of the next generation of vaccines and treatments by spearheading public-private collaborations. In September of 2023, Gritstone Bio locked in a $433 million contract to simply “conduct a mid-stage study of its self -amplifying mRNA COVID-19 vaccine candidate,” so there have been products in development for some time. Gritstone Bio has previously received funding from the Bill and Melinda Gates Foundation, which seeks to capitalize on their vaccine investments. Gritstone Bio’s partners also include BlackRock and State Street, official partners of the World Economic Forum. These bioweapon investments are too-big-to-fail, and the courts are not holding vaccine manufacturers accountable for harming millions, so it's likely that saRNA vaccines will be coming to the U.S. soon.

Sources include:

ChildrensHealthDefense.org

WhiteHouse.gov

Nature.com

Link